title: WHO European Region's strategy for elimination of measles and congenital rubella infection.
abstract: The WHO strategy for measles elimination in Europe includes the strengthening of surveillance and immunisation programmes in collaboration with European specific networks (EUVAC.NET and CCEE-Baltic) and Member States.
authors.affiliation: World Health Organization Regional Office for Europe, Copenhagen, Denmark.
authors.forename: F-X
authors.initials: FX
authors.lastname: Hanon
authors.forename: J
authors.initials: J
authors.lastname: Spika John
authors.forename: S
authors.initials: S
authors.lastname: Wassilak Steven
authors.forename: N
authors.initials: N
authors.lastname: Emiroglu
mesh_terms: D017677:Age Distribution; D000914:Antibodies, Viral / Q000096:biosynthesis; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D008457:Measles / Q000453:epidemiology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000627:therapeutic use*; D008459:Measles virus / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012410:Rubella Syndrome, Congenital / Q000453:epidemiology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000627:therapeutic use*; D012412:Rubella virus / Q000276:immunology*; D018571:Sentinel Surveillance; D014944:World Health Organization
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine; D012411:Rubella Vaccine